King Pharmaceuticals Inc - Net Worth and Insider Trading

King Pharmaceuticals Inc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, King Pharmaceuticals Inc owns 2 companies in total, including Palatin Technologies Inc (PTN) , and Novavax Inc (NVAX) .

Click here to see the complete history of King Pharmaceuticals Inc’s form 4 insider trades.

Insider Ownership Summary of King Pharmaceuticals Inc

Ticker	Comapny	Transaction Date	Type of Owner
PTN	Palatin Technologies Inc	2005-09-26	10 percent owner
NVAX	Novavax Inc	2004-07-16	10 percent owner

King Pharmaceuticals Inc Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

King Pharmaceuticals Inc Ownership Network

Ownership Network List of King Pharmaceuticals Inc

No Data

Ownership Network Relation of King Pharmaceuticals Inc

King Pharmaceuticals Inc Owned Company Details

What does Palatin Technologies Inc do?

Who are the key executives at Palatin Technologies Inc?

King Pharmaceuticals Inc is the 10 percent owner of Palatin Technologies Inc. Other key executives at Palatin Technologies Inc include Executive Vice President & CFO Stephen T Wills , director & President and CEO Carl Spana , and director & Exec. VP Research and Devel. Perry B Molinoff .

Palatin Technologies Inc (PTN) Insider Trades Summary

Over the past 18 months, King Pharmaceuticals Inc made no insider transaction in Palatin Technologies Inc (PTN). Other recent insider transactions involving Palatin Technologies Inc (PTN) include a net sale of 5,700 shares made by Deveer Robert K Jr , a net purchase of 5,002 shares made by Stephen T Wills , and a net sale of 400 shares made by Alan W Dunton .

In summary, during the past 3 months, insiders sold 11,700 shares of Palatin Technologies Inc (PTN) in total and bought 6,000 shares, with a net sale of 5,700 shares. During the past 18 months, 17,098 shares of Palatin Technologies Inc (PTN) were sold and 26,000 shares were bought by its insiders, resulting in a net purchase of 8,902 shares.

Palatin Technologies Inc (PTN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Palatin Technologies Inc Insider Transactions

No Available Data

King Pharmaceuticals Inc Mailing Address

Above is the net worth, insider trading, and ownership report for King Pharmaceuticals Inc. You might contact King Pharmaceuticals Inc via mailing address: 501 Fifth St, Bristol Tn 37620.

Discussions on King Pharmaceuticals Inc

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.